Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1401-1410 of 1,433) with videos related to

Pageof 144
Sort By:
Allergy|June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registryAndrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2026
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT CohortMatteo Bauckneht, Liliana Belgioia, Domenico Albano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
The Impact of Concordance Between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the Rome TrialAndrea Botticelli, Chiara Cremolini, Simone Scagnoli, et al.
Breast (Edinburgh, Scotland)|January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.
The Journal of Dermatological Treatment|May 7, 2024
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, et al.
ESMO Open|March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
Clinical and Molecular Allergy : CMA|December 21, 2021
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholderEster Di Agosta, Lorenzo Salvati, Monica Corazza, et al.
The Lancet. Oncology|July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisGuillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2025
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of lifeHenriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 29, 2014
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioningP Gisondi, P Amerio, G F Amoroso, et al.
Pageof 144

Showing results (1401-1410 of 1,433) with videos related to

Sort By:
Pageof 144
Allergy|June 21, 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registryAndrea Chiricozzi, Marina Talamonti, Clara De Simone, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2026
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT CohortMatteo Bauckneht, Liliana Belgioia, Domenico Albano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2025
The Impact of Concordance Between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the Rome TrialAndrea Botticelli, Chiara Cremolini, Simone Scagnoli, et al.
Breast (Edinburgh, Scotland)|January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.
The Journal of Dermatological Treatment|May 7, 2024
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Luciano Ibba, Ruggero Cascio Ingurgio, et al.
ESMO Open|March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
Clinical and Molecular Allergy : CMA|December 21, 2021
Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholderEster Di Agosta, Lorenzo Salvati, Monica Corazza, et al.
The Lancet. Oncology|July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisGuillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2025
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of lifeHenriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 29, 2014
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioningP Gisondi, P Amerio, G F Amoroso, et al.
Pageof 144